| Literature DB >> 31870355 |
Ken Otsuji1,2, Kazumasa Fukuda3, Midori Ogawa3, Yoshihisa Fujino4, Masayuki Kamochi5, Mitsumasa Saito3.
Abstract
BACKGROUND: The emergence of multi-drug resistant pathogens is an urgent health-related problem, and the appropriate use of antibiotics is imperative. It is often difficult to identify the causative bacteria in patients with aspiration pneumonia because tracheal aspirate contains contaminants of oral bacteria. We investigated the dynamics of microbiota in mechanically ventilated patients with aspiration pneumonia to develop a treatment strategy.Entities:
Keywords: Anaerobes; Aspiration pneumonia; Dynamics; Mechanical ventilation; Microbiota
Mesh:
Substances:
Year: 2019 PMID: 31870355 PMCID: PMC6929358 DOI: 10.1186/s12890-019-1021-5
Source DB: PubMed Journal: BMC Pulm Med ISSN: 1471-2466 Impact factor: 3.317
Characteristics of the subjects
| Subject | Sex | Primary diagnosisa | Co-morbidities | Interval | Interval | TD (mm) | TD (long/short)d | FIO2 (%) | Medication | Days | Mortalitye | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vasopressor | Immuno-modulator | Admission to recruitment | ICU stay | Mechanical ventilation | Hospital stay | ||||||||||
| 1 | M | Aspiration pneumoniae | CVD, COPD | 1 | 11 | 29 × 24 | 1.20 | 30–50 | + | – | 33 | 5 | 9 | 76 | survive |
| 2 | M | Asphyxia | Thyroid cancer, HT | 1 | 2 | 22 × 18 | 1.22 | 35–50 | – | – | 6 | 6 | 5 | 26 | survive |
| 3 | F | Drug overdose | Depression | 0 | 3 | 21 × 18 | 1.16 | 30–40 | + | – | 0 | 5 | 4 | 12 | survive |
| 4 | M | CPA | DCM, CRF | 1 | 15 | 23 × 19 | 1.21 | 45–60 | + | – | 0 | 9 | 14 | 14 | dead |
| 5 | M | Epidural hematoma | DM, HT, LC | 1 | 11 | 32 × 19 | 1.68 | 35–45 | – | – | 3 | 11 | 8 | 25 | survive |
| 6 | M | Subarachnoid hemorrhage | – | 0.5 | 12 | 24 × 20 | 1.20 | 35–50 | – | – | 0 | 4 | 4 | 30 | survive |
| 7 | M | Drug overdose | Depression | 0.5 | 4 | 23 × 23 | 1.00 | 21–50 | – | – | 0 | 2 | 2 | 4 | survive |
| 8 | F | Cerebral hemorrhage | SLE, DM, HT | 0.5 | 74 | 21 × 20 | 1.05 | 30–40 | – | – | 1 | 8 | 23 | 24 | survive |
| 9 | M | Heart failure | HF, DM, HT, CKD | 0.5 | 1 | 22 × 21 | 1.04 | 45–80 | – | – | 0 | 45 | 44 | 50 | dead |
| 10 | F | Convulsion | Epilepsy | 1 | 3 | 22 × 20 | 1.10 | 25–30 | – | – | 0 | 4 | 3 | 10 | survive |
| 11 | M | Convulsion | Epilepsy | 1.5 | 2 | 22 × 20 | 1.10 | 25–30 | – | – | 0 | 2 | 2 | 16 | survive |
| 12 | M | Aspiration pneumoniae | COPD | 0.5 | 1 | 20 × 19 | 1.05 | 50–60 | – | – | 1 | 15 | 36 | 37 | survive |
| 13 | F | Subarachnoid hemorrhage | – | 0.5 | 11 | NA | NA | 30 | – | – | 0 | 4 | 2 | 36 | survive |
| 14 | F | CPA | HF, CVD | 1 | 3 | 20 × 19 | 1.05 | 35–70 | – | – | 0 | 8 | 12 | 12 | survive |
| 15 | F | Cerebral hemorrhage | HT | 0.5 | 1 | 19 × 18 | 1.05 | 35 | + | – | 0 | 7 | 6 | 55 | survive |
| 16 | M | Subarachnoid hemorrhage | SAS | 0.5 | 3 | 19 × 19 | 1.00 | 35–90 | – | – | 0 | 30 | 51 | 96 | survive |
| 17 | M | CPA | CVD, HF, HT | 1 | 12 | 26 × 21 | 1.23 | 35–50 | + | – | 0 | 7 | 11 | 11 | survive |
| 18 | F | Aortic dissection | DM, HT | NA | NA | 24 × 17 | 1.41 | 45–70 | – | – | 4 | 16 | 16 | 16 | dead |
| 19 | M | Aspiration pneumoniae | CVD | 2 | 23 | 25 × 24 | 1.04 | 30–40 | – | – | 3 | 25 | 96 | 99 | survive |
| 20 | F | Aspiration pneumoniae | Brainstem dysfunction | 1 | 3 | 20 × 12 | 1.66 | 30–45 | – | – | 5 | 23 | 117 | 120 | survive |
| 21 | M | Aspiration pneumoniae | HF, DM, HT | NA | NA | 26 × 23 | 1.13 | 45–95 | + | – | 0 | 13 | 13 | 13 | survive |
| 22 | F | Convulsion | Epilepsy, DM | 0.5 | 11 | 22 × 18 | 1.22 | 40–50 | + | – | 0 | 7 | 7 | 29 | survive |
M male, F female, CPA cardiopulmonary arrest, CVD cerebral vascular disease, COPD chronic obstructive pulmonary disease, HT hypertension, DCM dilated cardiomyopathy, CRF chronic renal failure, DM diabetes mellitus, LC liver cirrhosis, SLE systemic lupus erythematosus, HF heart failure, CKD chronic kidney disease, SAS sleep apnea syndrome. aDiagnosis resulted in respiratory failure, bInterval I to (A) = time from tracheal intubation to sample collection (A), cInterval (A) to (B) = interval of collecting sample (A) and (B), (A) = samples collected within 2 h after intubation, (B) = samples collected just before administration of antibiotics, TD = tracheal diameter, dTD (long/short) = the ratio of longest/shortest tracheal diameter. eNone of the cases were died of aspiration pneumonia
Fig. 1Trial profile. aTwo cases were failure to obtain samples. bSix cases were negative result for PCR or extubated at (C)
Comparison between culture results and predominant phylotypes detected by clone library method of tracheal aspirate in each subjects
| Case | Culture Result at (B)a | Clone Library Analysis of 16S rRNA gene | Antibacterial Agent | ||
|---|---|---|---|---|---|
| Predominant Phylotype, Proportion (%) | |||||
| (A) | (B) | (C) | |||
| Culture result detected predominant phylotype (B) | |||||
| 1 | Piperacillin-Tazobactam | ||||
| 2 | Meropenem | ||||
| 3 | Ampicillin-Sulbactam | ||||
| 4 | Ampicillin-Sulbactam | ||||
| 5 | Ampicillin-Sulbactam | ||||
| 6 | Ampicillin-Sulbactam | ||||
| 7 | NA | Ampicillin-Sulbactam | |||
| 8 | Ampicillin-Sulbactam | ||||
| 10 | NA | Ampicillin-Sulbactam | |||
| 11 | NA | Ampicillin-Sulbactam | |||
| 12 | Meropenem | ||||
| 15 | NA | Ampicillin-Sulbactam | |||
| 16 | Ampicillin-Sulbactam | ||||
| 18 | NA | Ampicillin-Sulbactam | |||
| | |||||
| 19 | Ampicillin-Sulbactam | ||||
| 20 | Ampicillin-Sulbactam | ||||
| 21 | NA | Ampicillin-Sulbactam | |||
| 22 | Ampicillin-Sulbactam | ||||
| Culture result could not detect predominant phylotype (B) | |||||
| 9 | GPR (not detectable) +++, | Ampicillin-Sulbactam | |||
| 14 | No growth | Ampicillin-Sulbactam | |||
| 17 | NA | – | |||
| Not analyzed | |||||
| 13 | NA | NA | – | ||
NA not analyzed, (A) = samples collected within 2 h after intubation, (B) = samples collected just before administration of antibiotics, (C) = samples collected 48–72 h after the administration of antibiotics, Proportion = the ratio of clones of predominant phylotype to total clone. Matched result of culture result and predominant phylotype (B) are indicated as bold. Predominant phylotype detected after the administration of antibiotics are indicated with underline. aCulture results of case 4 and 9 are at (A). bOral flora include Streptococcus, Neisseria and Lactobacillus
Fig. 2The change of microbiota in saliva (I) and tracheal aspirate (II). Gray circle indicates the tracheal aspirate and gray triangle indicates the saliva. PC1: Principal Component 1, PC2: Principal Component 2, (A): samples collected within 2 h after intubation, (B): samples collected just before administration of antibiotics, (C): samples collected 48–72 h after the administration of antibiotics
Fig. 3Changes in proportion of anaerobes in tracheal aspirate from (A) to (B) during mechanical ventilation (individual cases). Proportion of anaerobes at “0” indicates proportion of anaerobes in tracheal aspirate (A), (A): samples collected within 2 h after intubation, (B): samples collected just before administration of antibiotics